Risk of a drug test? Everything about the detectability of Iboga & Ibogaine

The effect of Iboga is described in numerous studies and experience reports as addiction-breaking and helpful for various psychological disorders. No wonder the African plant with its main active ingredient ibogaine attracts so much attention.

Hardly any topic in psychedelic research arouses as much curiosity as the question of whether and how a substance can be detected in the body – and this of course also applies to iboga and ibogaine.

While classic drug tests usually only react to known and widespread substances such as THC or cocaine, iboga often remains hidden. But what really happens after consumption – and how long can traces of the active ingredient be detected in blood, urine or hair?

In this article, you will learn everything about common methods, drug tests and analysis procedures for detecting iboga. Enjoy reading!

Note: All described content is based on scientific sources or subjective experience reports and is not to be understood as instructions or recommendations for the consumption of iboga.

Tabernanthe iboga is a shrub from West Africa, mainly used by the Bwiti culture in Gabon as a ritual plant in connection with ceremonies.

In the Western world, the root bark of the iboga plant gained fame because it can help patients with various ailments such as depression, anxiety disorders, drug addiction, or other dependencies. Its addiction-breaking properties and its effects on the neurotransmitter system are responsible for these positive effects.

Numerous results from different studies confirm the effectiveness of the iboga root, yet its main active ingredient, ibogaine, is still rarely used in the treatment of affected individuals because no ibogaine-containing drugs are approved in most countries worldwide.

While iboga and ibogaine are banned in countries like France, Italy, and the USA, the legal situation is different in Germany, Gabon, and Mexico, for example: The plant is unregulated, meaning cultivation, possession, and consumption of the plant in a private setting are not explicitly prohibited here. The legality of iboga is therefore not currently restricted in Germany.

However, iboga may not be used or prescribed by medical professionals in Germany for medical and therapeutic treatments, as there is no drug approval for the plant's components and its active ingredient ibogaine in this country.

Many people wonder whether the use of iboga or ibogaine could be detected in a drug test, for example during traffic controls, at work, or during medical examinations.

The good news: Ibogaine is not detected in common standard tests.

Typical drug screenings test for known drugs such as THC, cocaine, opiates, amphetamines, or benzodiazepines. Ibogaine and its active metabolite noribogaine do not fall into any of these categories and therefore do not appear in these tests.

While common drug tests in everyday life are designed to detect only a specific combination of substance groups, specialized procedures are used in scientific research and forensic medicine to specifically detect substances such as ibogaine or its active metabolite noribogaine.

Such toxicological analyses are used to precisely determine the presence, concentration, and duration of action of a substance in the body. For this purpose, blood, urine, or hair samples are usually examined – depending on the question and the desired detection period.

The most common methods are:

• High-performance liquid chromatography (HPLC):
  This method separates the chemical components of a sample into their individual components. This makes it possible to precisely determine whether and in what quantity ibogaine or noribogaine are present.
  
  

• Gas chromatography-mass spectrometry (GC-MS):
  A very precise method that identifies molecules based on their mass. It is often used in forensic investigations to unequivocally identify psychoactive substances and legal highs.
  
  

• Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS):
  The most modern and sensitive method – it can detect even tiny amounts of ibogaine and is preferably used in research projects or toxicological laboratories.
  
  

These procedures are complex, expensive, and are not routinely used. They are mainly applied when a targeted substance analysis is required – for example, in clinical studies, poisoning cases, suspected doping, or scientific investigations into the pharmacokinetics of ibogaine.

In the body, ibogaine is usually detectable for only a short time: in blood for one to two days, in urine for up to five days.

Ibogaine and its active metabolite noribogaine can accumulate in hair structure over a longer period and remain detectable there for weeks or even months, depending on hair length.

However, there are currently only a few scientific studies that explicitly deal with the hair analysis of ibogaine. Some experts assume that traces of the active ingredient could be detectable for up to 90 days.

But this is irrelevant for conventional drug tests: an accidental positive result is practically impossible unless ibogaine is explicitly searched for. Targeted tests usually concern professional athletes, as iboga and its active ingredient ibogaine have been on the doping list of the International Olympic Committee since 1989.

However, the alkaloid from the iboga plant is not one of the substances that are tested in standard drug tests in doctor's offices, in road traffic, or at the workplace.

The answer to the question of detecting iboga or ibogaine through standardized rapid drug tests is simple: these tests do not detect the substance; furthermore, there is no simple testing procedure that could quickly detect this alkaloid.

Detecting the consumption of the iboga plant or ibogaine requires complex and targeted analytical methods that can only be performed in specialized laboratories.

Therefore, anyone experimenting with Iboga Microdosing does not need to worry that the use of iboga root could be accidentally detected in a drug test in traffic, at work, or during a medical examination.

• Kontrimaviciūte V., Larroque M., Briedis V., Bressolle F., Margout-Jantac D. (2005). Quantitation of ibogaine and 12-hydroxyibogamine in human plasma by liquid chromatography with fluorimetric detection. September 2005 Journal of Chromatography B 822(1-2):285-93. doi:10.1016/j.jchromb.2005.06.018

• Mazoyer C., Carlier J., Boucher A., Péoc'h M., Lemeur C., Gaillard Y. (2013). Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material. J Forensic Sci. 2013 Nov;58(6):1666-72. doi: 10.1111/1556-4029.12250

• Chèze M., Lenoan A., Deveaux M., Pépin G. (2008). Determination of ibogaine and noribogaine in biological fluids and hair by LC-MS/MS after Tabernanthe iboga abuse. Iboga alkaloids distribution in a drowning death case. Forensic Sci Int. 2008 Mar 21;176(1):58-66. doi: 10.1016/j.forsciint.2007.08.013

• Cherian, K.N., Keynan, J.N., Anker, L. et al. (2024). Magnesium–ibogaine therapy in veterans with traumatic brain injuries. Nat Med 30, 373–381 (2024). https://doi.org/10.1038/s41591-023-02705-w